- Home
- GH vs IBP Comparison
GH vs IBP Comparison
Compare GH & IBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- IBP
- Stock Information
- Founded
- GH 2011
- IBP 1977
- Country
- GH United States
- IBP United States
- Employees
- GH N/A
- IBP N/A
- Industry
- GH Medical Specialities
- IBP Homebuilding
- Sector
- GH Health Care
- IBP Consumer Discretionary
- Exchange
- GH Nasdaq
- IBP Nasdaq
- Market Cap
- GH 4.9B
- IBP 4.5B
- IPO Year
- GH 2018
- IBP 2014
- Fundamental
- Price
- GH $50.00
- IBP $194.58
- Analyst Decision
- GH Strong Buy
- IBP Buy
- Analyst Count
- GH 20
- IBP 11
- Target Price
- GH $54.35
- IBP $222.00
- AVG Volume (30 Days)
- GH 2.1M
- IBP 463.6K
- Earning Date
- GH 08-06-2025
- IBP 07-31-2025
- Dividend Yield
- GH N/A
- IBP 1.63%
- EPS Growth
- GH N/A
- IBP N/A
- EPS
- GH N/A
- IBP 8.78
- Revenue
- GH $773,996,000.00
- IBP $2,933,200,000.00
- Revenue This Year
- GH $23.14
- IBP N/A
- Revenue Next Year
- GH $21.42
- IBP $3.73
- P/E Ratio
- GH N/A
- IBP $22.16
- Revenue Growth
- GH 28.20
- IBP 4.30
- 52 Week Low
- GH $20.14
- IBP $150.83
- 52 Week High
- GH $53.42
- IBP $281.04
- Technical
- Relative Strength Index (RSI)
- GH 60.59
- IBP 70.56
- Support Level
- GH $48.07
- IBP $174.66
- Resistance Level
- GH $53.42
- IBP $197.16
- Average True Range (ATR)
- GH 2.25
- IBP 6.97
- MACD
- GH -0.12
- IBP 2.48
- Stochastic Oscillator
- GH 55.56
- IBP 94.82
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About IBP Installed Building Products Inc.
Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.